NASDAQ: BTTX - Better Therapeutics, Inc.

六个月盈利: -99.12%
部门: Healthcare

促销时间表 Better Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions.

更多详情
In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

EBITDA -0.0057
EV/EBITDA -0.7443
IPO date 2021-10-28
ISIN US08773T1043
Industry Biotechnology
P/BV 3.35
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 1.8E-5
Сайт https://www.bettertx.com
Цена ао 0.0137
Число акций ао 0.02356 млрд
每日价格变化: 0% (0.0001)
每周价格变化: 0% (0.0001)
每月价格变化: 0% (0.0001)
3个月内价格变化: 0% (0.0001)
六个月内的价格变化: -99.12% (0.0113)
每年价格变化: -99.95% (0.195)
3年内价格变化: -100% (4.65)
5年内价格变化: 0% (0.0001)
10年价格变化: 0% (0.0001)
年初以来价格变化: 0% (0.0001)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV -35.64 0
P/E 0 0
EV/EBITDA -0.8149 0
全部的: 2.5

效率

姓名 意义 年级
ROA, % -107.6 0
ROE, % -221.99 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.389 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 523.39 10
盈利能力 EPS, % 217.59 10
全部的: 8
更多详情

机构 体积 分享, %
MMCAP International, Inc. SPC 356270 0.71
Citadel Advisors Llc 216165 0.43
Vanguard Group Inc 198154 0.4
Geode Capital Management, LLC 168821 0.34
Millennium Management LLC 128749 0.26
Blackrock Inc. 88635 0.18
Capital Investment Advisory Services, LLC 71000 0.14
State Street Corporation 58600 0.12
Susquehanna International Group, LLP 38057 0.08
Corient Private Wealth LLC 29180 0.06



导师 职称 支付 出生年份
Mr. David P. Perry M.B.A. Co-Founder & Executive Chairman 260k 1968 (57 年)
Mr. Frank L. Karbe CEO, Interim CFO, President & Director 533.37k 1968 (57 年)
Dr. Mark A. Berman M.D. Chief Medical Officer 573.75k 1976 (49 年)
Ms. Kristin Wynholds Chief Product Officer 519.07k 1973 (52 年)
Mr. Andres Camacho Senior VP of Technology & Head of Engineering N/A
Ms. Angela Willis Senior Vice President of Market Access N/A
Leslie Miller Controller N/A
Ms. Jessica Meng Chief Commercial Officer N/A

地址: United States, San Francisco. CA, 548 Market Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.bettertx.com